Multiple sclerosis: current pathophysiological concepts
D M Wingerchuk, C F Lucchinetti, J H Noseworthy, D M Wingerchuk, C F Lucchinetti, J H Noseworthy
Abstract
Multiple sclerosis (MS) is an often disabling disease primarily affecting young adults that exhibits extraordinary clinical, radiological, and pathological heterogeneity. We review the following: (a) known environmental and genetic factors that contribute to MS susceptibility; (b) current knowledge regarding fundamental pathophysiological processes in MS, including immune cell recruitment and entry into the central nervous system (CNS), formation of the plaque, and orchestration of the immune response; (c) descriptive and qualitative distinct pathological patterns in MS and their implications; (d) the evidence supporting the causative role of direct toxins, cell-mediated and humorally mediated immune mechanisms, and the concept of a "primary oligodendrogliopathy" in demyelination and axonal injury; (e) the potential benefits of inflammation; (f) the prospects for remyelination; and (g) therapeutic implications and approaches suggested by putative pathophysiological mechanisms.
Source: PubMed
Prochains essais cliniques
-
October University for Modern Sciences and ArtsRecrutement
-
Uskudar UniversityPas encore de recrutementDouleur musculo-squelettique | Maladies professionnellesTurquie (Türkiye)
-
Milton S. Hershey Medical CenterAxogen CorporationPas encore de recrutementCancer de la parotide | Parotidectomie | Le syndrome de Frey | Parotidectomie, résultats rapportés par les patients | Tumeur de la glande parotide
-
University of the Italian SwitzerlandUniversita di VeronaPas encore de recrutementFardeau des soignants | La détresse psychologiqueSuisse
-
Ain Shams UniversityPas encore de recrutementHip Abductor Insufficiency Following Total Hip Arthroplasty
-
University of CalgaryPas encore de recrutementHypospadias | Obstruction de la jonction urétéro-pelvienneCanada
-
Reinovax Biologics Co., LTDPas encore de recrutementA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccineMaladie infectieuse à pneumocoqueChine
-
Research IncRecrutementPostoperative Nasal Fibrosis After RhinoplastyColombie
-
Abramson Cancer Center at Penn MedicinePas encore de recrutement
-
Aligos TherapeuticsPas encore de recrutementParticipants en bonne santéÉtats-Unis
-
PT Equilab InternationalNestle IndonesiaRecrutement
-
Stanford UniversityPas encore de recrutement